TBA, San Francisco, CA
July 13-14, 2011
Arrowhead’s Drug Repositioning and Indication Expansion Conference has been organized to highlight key trends, case studies and tool sets for identifying repositioning opportunities as well as the technical, regulatory and intellectual property challenges that arise out of these efforts. Why Attend: - Learn the opportunities and challenges of drug rediscovery
- Hear successful drug repositioning case studies
- Determine how to find drug repositioning opportunities
- Learn about product life cycle management through new indications and combination therapy
|
|